학술논문
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment
Document Type
Article
Author
Nowicka, Malgorzata ; Hilton, Laura K. ; Ashton-Key, Margaret; Hargreaves, Chantal E.; Lee, Chern; Foxall, Russell; Carter, Matthew J.; Beers, Stephen A.; Potter, Kathleen N.; Bolen, Christopher R.; Klein, Christian; Knapp, Andrea; Mir, Farheen; Rose-Zerilli, Matthew; Burton, Cathy; Klapper, Wolfram; Scott, David W.; Sehn, Laurie H.; Vitolo, Umberto; Martelli, Maurizio; Trneny, Marek; Rushton, Christopher K.; Slack, Graham W.; Farinha, Pedro; Strefford, Jonathan C.; Oestergaard, Mikkel Z.; Morin, Ryan D.; Cragg, Mark S.
Source
In Blood Advances 10 August 2021 5(15):2945-2957
Subject
Language
ISSN
2473-9529